Case report highlights severe neutropenia from propylthiouracil in a postpartum thyroid storm patient, indicating risks of antithyroid treatment.
Though it stands as the first line and life-saving therapeutic option in thyroid storms, Propylthiouracil (PTU) remains a double-edged sword, fraught with rare yet potentially life-threatening adverse effects. This case report underscores PTU-induced neutropenia in a 34-year-old Saudi female with a two-year history of Grave’s disease. Having ceased antithyroid medications on her own accord and being in the third month postpartum, these factors together served as sufficient catalysts to precipitate a severely symptomatic thyrotoxic crisis. The patient was managed with supportive care, hydrocortisone, propranolol, and PTU; yet on the fourth day following admission to the intensive care unit, her neutrophil count plummeted precipitously, indicating severe PTU-induced neutropenia, thereby rendering PTU permanently contraindicated. This case report illustrates that management of thyroid storm remains achievable without PTU; however, definitive treatment ultimately necessitates thyroidectomy, particularly when radioactive iodine is contraindicated, as was the case here owing to the postpartum state.
No takes yet. Share an insight, caveat, or question.
Galadari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: